Escitalopram-Induced Progressive Cervical Dystonia

Psychosomatics

Volumn 56, Issue 5, 2015, Pages 572-575

  Morgan, Robert Joseph ^a   Dolenc, Tamara J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; CELECOXIB; CITALOPRAM; CLONAZEPAM; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DIPHENHYDRAMINE; ESCITALOPRAM; OMEPRAZOLE; RITUXIMAB; TAMSULOSIN; SEROTONIN UPTAKE INHIBITOR;

AGED; ANXIETY DISORDER; ARTICLE; BEDTIME DOSAGE; CASE REPORT; CERVICAL DYSTONIA; COGNITIVE THERAPY; DRUG DOSE INCREASE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HUMAN; MAJOR DEPRESSION; MALE; MULTIPLE CYCLE TREATMENT; NAUSEA; PHYSIOTHERAPY; SLEEP DISORDER; WALDENSTROEM MACROGLOBULINEMIA; CHEMICALLY INDUCED; DEPRESSIVE DISORDER, MAJOR; TORTICOLLIS;

AGED; CITALOPRAM; DEPRESSIVE DISORDER, MAJOR; HUMANS; MALE; SEROTONIN UPTAKE INHIBITORS; TORTICOLLIS;

EID: 84941024901     PISSN: 00333182     EISSN: 15457206     Source Type: Journal    
DOI: 10.1016/j.psym.2014.09.008     Document Type: Article

References (28)

1. Walker L. Sertraline-induced akathisia and dystonia misinterpreted as a panic attack. Psychiatr Serv 2002, 53(11):1477-1478.
2. Boyle S.F. SSRIs and movement disorders. J Am Acad Child Adolesc Psychiatry 1999, 38(4):354-355.
3. Parvin M.M., Swartz C.M. Dystonic rabbit syndrome from citalopram. Clin Neuropharmacol 2005, 28(6):289-291.
4. Chen P.Y., Lin P.Y., Tien S.C., Chang Y.Y., Lee Y. Duloxetine-related tardive dystonia and tardive dyskinesia: a case report. Gen Hosp Psychiatry 2010, 32(6):646.e9-646.e11.
5. Lauterbach E.C., Meyer J.M., Simpson G.M. Clinical manifestations of dystonia and dyskinesia after SSRI administration. J Clin Psychiatry 1997, 58(9):403-404.
6. Reccoppa L., Welch W.A., Ware M.R. Acute dystonia and fluoxetine. J Clin Psychiatry 1990, 51(11):487.
7. George M.S., Trimble M.R. Dystonic reaction associated with fluvoxamine. J Clin Psychopharmacol 1993, 13(3):220-221.
8. Lewis C.F., DeQuardo J.R., Tandon R. Dystonia associated with trazodone and sertraline. J Clin Psychopharmacol 1997, 17(1):64-65.
9. Najjar F., Price L.H. Citalopram and dystonia. J Am Acad Child Adolesc Psychiatry 2004, 43(1):8-9.
10. Patel O.P., Simon M.R. Oculogyric dystonic reaction to escitalopram with features of anaphylaxis including response to epinephrine. Int Arch Allergy Immunol 2006, 140(1):27-29.
11. Garcia Ruiz P.J., Cabo I., Bermejo P.G., Carnal P. Escitaloparm-induced paroxysmal dystonia. Clin Neuropharmacol 2007, 30(2):124-126.
12. Bilen S., Saka M., Ak F., Oztekin N. Persistent dystonia induced by fluoxetine. Intern Med J 2008, 38(8):672-674.
13. LeDoux M.S. Dystonia: phenomenology. Parkinsonism Relat Disord 2012, 18(1 Suppl):S162-S164.
14. Leo R.J. Movement disorders associated with the serotonin selective reuptake inhibitors. J Clin Psychiatry 1996, 57(10):449-454.
15. Gill H.S., DeVane C.L., Risch S.C. Extrapyramidal symptoms associated with cyclic antidepressant treatment: a review of the literature and consolidating hypotheses. J Clin Psychopharmacol 1997, 17(5):377-389.
16. Basu B., Gangopadhyay T., Dutta N., Mandal B., De S., Mondal S. A case of akathisia induced by escitalopram: case report & review of literature. Curr Drug Saf 2014, 9(1):56-59.
17. Rosenhagen M.C., Schmidt U., Weber F., Steiger A. Combination therapy of lamotrigine and escitalopram may cause myoclonus. J Clin Psychopharmacol 2006, 26(3):346-347.
18. Ak S., Anil Yagcioglu A.E. Escitalopram-induced Parkinsonism. Gen Hosp Psychiatry 2014, 36(1):126.e1-126.e2.
19. Wise M. Citalopram-induced bruxism. Br J Psychiatry 2001, 178:182.
20. Duggal H.S., Mendhekar D.N. A case report of reemergence of antipsychotic-induced dyskinesia with citalopram. J Clin Psychiatry 2007, 68(5):803.
21. Kapur S., Remington G. Serotonin-dopamine interaction and its relevance to schizophrenia. Am J Psychiatry 1996, 153(4):466-476.
22. Dewey S.L., Smith G.S., Logan J., et al. Serotonergic modulation of striatal dopamine measured with positron emission tomography (PET) and in vivo microdialysis. J Neurosci 1995, 15(1 Pt 2):821-829.
23. MacGillivray L., Reynolds K.B., Sickand M., Rosebush P.I., Mazurek M.F. Inhibition of the serotonin transporter induces microglial activation and downregulation of dopaminergic neurons in the substantia nigra. Synapse 2011, 65(11):1166-1172.
24. Madhusoodanan S., Alexeenko L., Sanders R., Brenner R. Extrapyramidal symptoms associated with antidepressants-a review of the literature and an analysis of spontaneous reports. Ann Clin Psychiatry 2010, 22(3):148-156.
25. Gerber P.E., Lynd L.D. Selective serotonin-reuptake inhibitor-induced movement disorders. Ann Pharmacother 1998, 32(6):692-698.
26. Staat K., Segatore M. The phenomenon of chemo brain. Clin J Oncol Nurs 2005, 9(6):713-721.
27. Rocha A., Coelho E.B., Sampaio S.A., Lanchote V.L. Omeprazole preferentially inhibits the metabolism of (+)-(S)-citalopram in healthy volunteers. Br J Clin Pharmacol 2010, 70(1):43-51.
28. Gjestad C., Westin A.A., Skogvoll E., Spigset O. Effect of proton pump inhibitors on the serum concentrations of the selective serotonin reuptake inhibitors citalopram, escitalopram and sertraline. Ther Drug Monit 2014, PMID: 24887634 [epub ahead of print].